Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset.
about
The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomesMyositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research.Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis.The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.Consensus-based recommendations for the management of juvenile dermatomyositis.Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies.Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.The Clinical Features of Myositis-Associated Autoantibodies: a Review.Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.Serological subsets of juvenile idiopathic inflammatory myopathies--an update.The cutaneous and systemic findings associated with nuclear matrix protein-2 antibodies in adult dermatomyositis patients.Autoimmune Myopathies.Monitoring change in volume of calcifications in juvenile idiopathic inflammatory myopathy: a pilot study using low dose computed tomography.Sex Differences in Pediatric Rheumatology.Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis.Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort.Recent developments on treatment strategies and the prognosis of dermatomyositis: a review.Efficacy and safety of cyclophosphamide treatment in severe juvenile dermatomyositis shown by marginal structural modelling.Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients.Bench to bedside review of myositis autoantibodies.CD19+CD24hiCD38hi B Cells Are Expanded in Juvenile Dermatomyositis and Exhibit a Pro-Inflammatory Phenotype After Activation Through Toll-Like Receptor 7 and Interferon-α.
P2860
Q37022721-EA0F500B-0F7D-4DEE-9091-2D6FDB8CE87EQ37368405-506CAA80-27B8-45EB-BFAF-8170590D0ADFQ37388175-9C19A25C-D253-43A3-8AA2-5B8A071408D8Q37427265-5371DED9-A6ED-4FC1-86C6-047F514D528CQ37617000-E2A7011A-1B68-4D2A-A251-3BB38656F921Q38281749-32BB7310-11FE-4A90-889F-35D885F5DE77Q38534871-666B7FBA-35C4-4F44-AA2C-D5A540953D9FQ38603422-1D2811BC-9D22-4867-928E-CF493A523CFBQ38646384-ACFE6B63-16FA-495C-A7F4-C506B90965A8Q38664251-D83B5B4A-33DC-4700-9931-FD59335D9E43Q38995102-7F478EAF-1583-4409-AD58-A02F092220FEQ39030495-6E3C37E1-1841-4F63-B31D-DD66F1DAB2D1Q39148036-E2382F78-F350-4DE1-812C-0FD468503E64Q40041622-095D9912-C87B-4FA8-B7C5-92EAC0DB2603Q40479791-A09B9889-F20F-4D25-BAC6-4E6B6FF392F6Q42632915-0DCDDF82-C40E-498C-969A-E421943C57EEQ47436112-1563315F-CA89-49D5-A399-AC1179166889Q49998617-ED4F3013-F906-42ED-83F2-82777A83CEDFQ51192752-54F9FF84-AC1F-489D-9694-66318FB14DB7Q55425108-71EB54C6-FDDC-46D0-AC54-DCA54EB7B6D4Q55487166-09287768-E4F1-4AB4-9285-AFC94CD3E0A5
P2860
Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Calcinosis in juvenile dermato ...... atus and age at disease onset.
@ast
Calcinosis in juvenile dermato ...... atus and age at disease onset.
@en
Calcinosis in juvenile dermato ...... atus and age at disease onset.
@nl
type
label
Calcinosis in juvenile dermato ...... atus and age at disease onset.
@ast
Calcinosis in juvenile dermato ...... atus and age at disease onset.
@en
Calcinosis in juvenile dermato ...... atus and age at disease onset.
@nl
prefLabel
Calcinosis in juvenile dermato ...... atus and age at disease onset.
@ast
Calcinosis in juvenile dermato ...... atus and age at disease onset.
@en
Calcinosis in juvenile dermato ...... atus and age at disease onset.
@nl
P2093
P2860
P50
P356
P1433
P1476
Calcinosis in juvenile dermato ...... atus and age at disease onset.
@en
P2093
Gavin Shaddick
Harsha Gunawardena
Juvenile Dermatomyositis Research Group
Katie Arnold
Neil J McHugh
Zoe E Betteridge
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEU259
P577
2014-07-01T00:00:00Z